Shingles vaccine linked to 24% lower dementia risk in large study
A large observational study finds people vaccinated against shingles (herpes zoster) showed a 24 percent lower risk of developing dementia — a finding that, if causal, would make shingles vaccination among the most cost-effective available interventions against dementia.
- The association held after adjusting for age, comorbidities, and healthcare utilisation, reducing but not eliminating potential confounding
- Proposed mechanism: shingles triggers neuroinflammatory cascades in the central nervous system; the vaccine may blunt those cascades
- Two vaccines exist (Zostavax and the more effective Shingrix); the study cohort vaccine-mix matters for interpreting absolute effect sizes